Fosaprepitant Dimeglumine 67184-0540

Product NDC

67184-0540

Manufacturer: Qilu Pharmaceutical Co., Ltd.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: September 8, 2020
Listing Expires: December 31, 2027
Application: ANDA213106

Need to source Fosaprepitant Dimeglumine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Fosaprepitant Dimeglumine	150 mg/5mL

Drug Class

Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]

Packaging Options(1)

67184-0540-01

1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE

View →